Adc Therapeutics SA (NYSE: ADCT) kicked off on Friday, down -4.36% from the previous trading day, before settling in for the closing price of $3.9. Over the past 52 weeks, ADCT has traded in a range of $1.05-$4.80.
Healthcare Sector giant saw their annual sales surged by 1.38% over the last five years. While this was happening, its average annual earnings per share was recorded 12.76%. With a float of $101.94 million, this company’s outstanding shares have now reached $112.63 million.
Adc Therapeutics SA (ADCT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adc Therapeutics SA is 17.71%, while institutional ownership is 52.66%.
Adc Therapeutics SA (ADCT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.29 earnings per share (EPS), higher than consensus estimate (set at -0.41) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.36% during the next five years compared to 1.38% growth over the previous five years of trading.
Adc Therapeutics SA (NYSE: ADCT) Trading Performance Indicators
Take a look at Adc Therapeutics SA’s (ADCT) current performance indicators. Last quarter, stock had a quick ratio of 4.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.11 in one year’s time.
Technical Analysis of Adc Therapeutics SA (ADCT)
Analysing the last 5-days average volume posted by the [Adc Therapeutics SA, ADCT], we can find that recorded value of 2.06 million was better than the volume posted last year of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 52.71%.
During the past 100 days, Adc Therapeutics SA’s (ADCT) raw stochastic average was set at 52.23%, which indicates a significant increase from 47.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.44 in the past 14 days, which was higher than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.10, while its 200-day Moving Average is $2.98. Now, the first resistance to watch is $3.95. This is followed by the second major resistance level at $4.16. The third major resistance level sits at $4.28. If the price goes on to break the first support level at $3.62, it is likely to go to the next support level at $3.50. Now, if the price goes above the second support level, the third support stands at $3.29.
Adc Therapeutics SA (NYSE: ADCT) Key Stats
The company with the Market Capitalisation of 462.06 million has total of 123,877K Shares Outstanding. Its annual sales at the moment are 70,840 K in contrast with the sum of -157,850 K annual income. Company’s last quarter sales were recorded 16,430 K and last quarter income was -40,970 K.
